Under construction – not a live service
Sign in
Enrolling by invitationNo phase

Resilient HIV Implementation Science With SGM Youths Using Evidence

Key facts

Where
Lusaka, ZambiaSee the site

Could this be for you?

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 15 and 24 years old?

Where in Zambia

  • CIHEB Zambia LimitedLusaka, ZambiaNo longer taking part

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
University of Maryland, Baltimore
Trial code
NCT06350682
Record updated
19 May 2026
Original description
The Resilient HIV Implementation Science with SGM Youths using Evidence (RISE) Clinical Research Center will use a Type 2 hybrid-effectiveness-implementation study to evaluate the effectiveness and implementation of HMP, a youth-tailored digital health platform. It is hypothesized that SGM youths in the HMP intervention group will demonstrate improved PrEP initiation and viral load suppression over 12 months compared to the delayed HMP group.Read full original descriptionShow less

The Resilient HIV Implementation Science with SGM Youths using Evidence (RISE) Clinical Research Center will use a Type 2 hybrid-effectiveness-implementation study to evaluate the effectiveness and implementation of HMP, a youth-tailored digital health platform. It is hypothesized that SGM youths in the HMP intervention group will demonstrate improved PrEP initiation and viral load suppression over 12 months compared to the delayed HMP group.

Inclusion: Male sex at birth; Age 15-24 years; Own an Android or iOS smartphone; Had receptive or insertive sex with another man in the past 12 months; Receiving care or prevention services at the CBSP-associated with the CRPS at the time of study.

Exclusion: Less than 15 years old; Greater than 24 years old; Inability or cognitively impaired to provide consent; Does not own an Android or iOS smartphone.

ClinicalTrials.gov NCT06350682